I am sure it is the Government's starting position and the starting position of any rational person would be to support measures that are aimed at tackling antimicrobial resistance. There was a deficiency in identifying a potential problem within this regulation and it was not noticed that it could have an effect on our member state. That is the issue we have been discussing for the past couple of hours and I know about it because as MEPs we would have been dependent on the briefing we would receive from the permanent representation, that is, the Irish Government's position, to highlight potential issues for Ireland and they were never highlighted in this regard. The witnesses have acknowledged that the Department did not see it. Does the Department intend to put in place a basis whereby the extensive consultation the witnesses have mentioned happens while the files are in process as opposed to happening after the regulation has been signed off and into the future?